SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : QDEL - Quidel more quick diagnosis
QDEL 24.35+14.3%Nov 21 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Ambrym Man who wrote (613)4/14/1997 1:55:00 PM
From: Robert Busse   of 1693
 
There is more here than meets the eye in my opinion. The timing of this suit seems to be a deliberate attempt to push Qdel's price down at a time when (I believe) they are on the verge of reporting excellent earnings. Smells kinda fishy on BD's part to me.
It is my understanding that Qdel had (and still has) an opinion from its patent counsel that Qdel was not "infringing" on BD's patent in its various tests. Even if Qdel's patent counsel is wrong (a point which I am certainly not prepared to concede), it seems to me that Qdel's reliance on this opinion would definitely establish that Qdel did not in any way act "wilfully" as the suit alleges. Hopefully, this should eliminate any chance of treble damages for "willfully" infringing on BD's patent (presuming there is any merit to BD's suit at all). Although it may take a few weeks or more likely months, don't be surprised to see this suit settled shortly. We all are experiencing the worst possible combination at the present-bad news about our company in a bad market. Uncertainty is what is hurting Qdel right now- there is still nothing but good news ahead on all other fronts (and hopefully on the BD suit as well). Be patient, hang in there, and don't lose your focus, everyone.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext